Universal Health Realty Income Trust (UHT) 10-Q 5 Aug 16 2016 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2016	Jul. 31, 2016
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q2
Trading Symbol	UHT
Entity Registrant Name	UNIVERSAL HEALTH REALTY INCOME TRUST
Entity Central Index Key	798,783
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		13,589,035

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Revenues:
Base rental - UHS facilities		$ 4,079	$ 3,991	$ 8,160	$ 7,897
Base rental - Non-related parties		9,030	8,806	17,845	17,675
Bonus rental - UHS facilities		1,193	1,150	2,439	2,368
Tenant reimbursements and other - Non-related parties		1,943	1,894	3,816	3,903
Tenant reimbursements and other - UHS facilities		216	208	427	408
Revenues, Total		16,461	16,049	32,687	32,251
Expenses:
Depreciation and amortization		5,543	5,870	10,979	11,393
Advisory fees to UHS		781	693	1,548	1,359
Other operating expenses		4,540	4,738	8,940	9,460
Transaction costs		64	147	146	204
Costs and Expenses, Total		10,928	11,448	21,613	22,416
Income before equity in income of unconsolidated limited liability companies ("LLCs"), interest expense and gain on property exchange		5,533	4,601	11,074	9,835
Equity in income of unconsolidated LLCs	[1]	1,227	673	2,286	1,265
Gain on property exchange			8,742		8,742
Interest expense, net		(2,237)	(2,012)	(4,409)	(4,142)
Net income		$ 4,523	$ 12,004	$ 8,951	$ 15,700
Basic earnings per share		$ 0.34	$ 0.90	$ 0.67	$ 1.18
Diluted earnings per share		$ 0.34	$ 0.90	$ 0.67	$ 1.18
Weighted average number of shares outstanding - Basic		13,397	13,286	13,352	13,284
Weighted average number of share equivalents		7	10	7	11
Weighted average number of shares and equivalents outstanding - Diluted		13,404	13,296	13,359	13,295
[1]	Our share of net income for the three and six months ended June 30, 2016 includes approximately $293,000 and $589,000, respectively, of interest income earned by us on an advance made to Arlington Medical Properties, LLC (advance balance payable to us is approximately $22.1 million as of June 30, 2016). There were no advances outstanding during the first six months of 2015, therefore there was no interest income earned by us for the three and six months ended June 30, 2015. Also, as mentioned above, effective February 1, 2016, we purchased an additional 10% of the ownership interest in Arlington Medical Properties, LLC thereby increasing our ownership interest to 85%, from 75% previously.

Condensed Consolidated Stateme3

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 4,523	$ 12,004	$ 8,951	$ 15,700
Other comprehensive income/(loss):
Unrealized losses on interest rate caps	(66)	(18)	(68)	(79)
Amortization of interest rate cap fees	23	23	46	46
Total other comprehensive income/(loss):	(43)	5	(22)	(33)
Total comprehensive income	$ 4,480	$ 12,009	$ 8,929	$ 15,667

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Real Estate Investments:
Buildings and improvements and construction in progress	$ 494,276	$ 469,933
Accumulated depreciation	(129,482)	(121,161)
Real Estate Investment Property, Net, Total	364,794	348,772
Land	46,000	41,724
Net Real Estate Investments	410,794	390,496
Investments in and advances to limited liability companies ("LLCs")	36,871	31,597
Other Assets:
Cash and cash equivalents	4,707	3,894
Base and bonus rent receivable from UHS	2,314	2,116
Rent receivable - other	4,494	4,292
Intangible assets (net of accumulated amortization of $24.6 million and $25.1 million at June 30, 2016 and December 31, 2015, respectively)	20,971	19,757
Deferred charges and other assets, net	7,273	6,351
Total Assets	487,424	458,503
Liabilities:
Line of credit borrowings	167,000	142,150
Mortgage and other notes payable, non-recourse to us, net	108,500	110,156
Accrued interest	514	504
Accrued expenses and other liabilities	6,787	6,807
Tenant reserves, deposits and prepaid rents	4,437	3,844
Total Liabilities	287,238	263,461
Equity:
Preferred shares of beneficial interest, $.01 par value; 5,000,000 shares authorized; none issued and outstanding
Common shares, $.01 par value; 95,000,000 shares authorized; issued and outstanding: 2016 - 13,588,951; 2015 -13,327,020	136	133
Capital in excess of par value	255,305	241,700
Cumulative net income	564,237	555,286
Cumulative dividends	(619,376)	(601,983)
Accumulated other comprehensive loss	(116)	(94)
Total Equity	200,186	195,042
Total Liabilities and Equity	$ 487,424	$ 458,503

Condensed Consolidated Balance5

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Jun. 30, 2016	Dec. 31, 2015
Statement Of Financial Position [Abstract]
Intangible assets, accumulated amortization	$ 24.6	$ 25.1
Preferred shares of beneficial interest, par value	$ 0.01	$ 0.01
Preferred shares of beneficial interest, shares authorized	5,000,000	5,000,000
Preferred shares of beneficial interest, issued	0	0
Preferred shares of beneficial interest, outstanding	0	0
Common shares, par value	$ 0.01	$ 0.01
Common shares, shares authorized	95,000,000	95,000,000
Common shares, issued	13,588,951	13,327,020
Common shares, outstanding	13,588,951	13,327,020

Condensed Consolidated Stateme6

Condensed Consolidated Statement of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Cash flows from operating activities:
Net income	$ 8,951,000	$ 15,700,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	11,027,000	11,442,000
Amortization of debt premium	(111,000)	(111,000)
Stock-based compensation expense	228,000	205,000
Gain on property exchange		(8,742,000)
Income in excess of cash distributions from LLCs		(198,000)
Changes in assets and liabilities:
Rent receivable	(400,000)	(135,000)
Accrued expenses and other liabilities	(446,000)	(294,000)
Tenant reserves, deposits and prepaid rents	593,000	371,000
Accrued interest	10,000	(63,000)
Other, net	157,000	(360,000)
Net cash provided by operating activities	20,009,000	17,815,000
Cash flows from investing activities:
Investments in LLCs	(5,454,000)	(392,000)
Repayments of advances made to LLC	421,000
Cash distributions in excess of income from LLCs	104,000
Cash distribution of refinancing proceeds from LLCs		1,045,000
Additions to real estate investments, net	(4,143,000)	(3,190,000)
Cash received for property exchange	0	2,000,000
Net cash paid for acquisition of properties	(27,943,000)	(16,765,000)
Cash paid to acquire minority interests in majority-owned LLCs		(2,250,000)
Net cash used in investing activities	(37,015,000)	(19,552,000)
Cash flows from financing activities:
Net borrowings on line of credit	24,850,000	25,525,000
Repayments of mortgages and other notes payable	(1,596,000)	(6,559,000)
Financing costs paid	(307,000)	(1,000,000)
Dividends paid	(17,393,000)	(16,966,000)
Partial settlement of dividend equivalent rights	(1,000)
Issuance of shares of beneficial interest, net	12,266,000	1,226,000
Net cash provided by financing activities	17,819,000	2,226,000
Increase in cash and cash equivalents	813,000	489,000
Cash and cash equivalents, beginning of period	3,894,000	3,861,000
Cash and cash equivalents, end of period	4,707,000	4,350,000
Supplemental disclosures of cash flow information:
Interest paid	$ 4,251,000	4,084,000
Property Exchange Transaction:
Net assets acquired in property exchange		9,886,000
Net assets relinquished in property exchange		$ (3,144,000)

General

General	6 Months Ended
	Jun. 30, 2016
Organization Consolidation And Presentation Of Financial Statements [Abstract]
General	(1) General This Quarterly Report on Form 10-Q is for the quarter ended June 30, 2016. In this Quarterly Report, “we,” “us,” “our” and the “Trust” refer to Universal Health Realty Income Trust and its subsidiaries. In this Quarterly Report on Form 10-Q, the term “revenues” does not include the revenues of the unconsolidated limited liability companies (“LLCs”) in which we have various non-controlling equity interests ranging from 33% to 95%. As of June 30, 2016, we had investments in five jointly-owned LLCs/LPs which own medical office buildings, all of which are accounted for by the equity method (see Note 5). These LLCs are included in our financial statements for all periods presented on an unconsolidated basis since they are not variable interest entities for which we are the primary beneficiary, nor do we hold a controlling voting interest. The financial statements included herein have been prepared by us, without audit, pursuant to the rules and regulations of the SEC and reflect all normal and recurring adjustments which, in our opinion, are necessary to fairly present results for the interim periods. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although we believe that the accompanying disclosures are adequate to make the information presented not misleading. It is suggested that these financial statements be read in conjunction with the financial statements, the notes thereto and accounting policies included in our Annual Report on Form 10-K for the year ended December 31, 2015.

Relationship with Universal Hea

Relationship with Universal Health Services, Inc. ("UHS") and Related Party Transactions	6 Months Ended
	Jun. 30, 2016
Related Party Transactions [Abstract]
Relationship with Universal Health Services, Inc. ("UHS") and Related Party Transactions	(2) Relationship with Universal Health Services, Inc. (“UHS”) and Related Party Transactions Leases: We commenced operations in 1986 by purchasing properties of certain subsidiaries from UHS and immediately leasing the properties back to the respective subsidiaries. Most of the leases were entered into at the time we commenced operations and provided for initial terms of 13 to 15 years with up to six additional 5-year renewal terms. The current base rentals and lease and rental terms for each facility are provided below. The base rents are paid monthly and each lease also provides for additional or bonus rents which are computed and paid on a quarterly basis based upon a computation that compares current quarter revenue to a corresponding quarter in the base year. These hospital leases with subsidiaries of UHS are unconditionally guaranteed by UHS and are cross-defaulted with one another. The combined revenues generated from the leases on the UHS hospital facilities accounted for approximately 24% and 25% of our consolidated revenues for the three months ended June 30, 2016 and 2015, respectively, and approximately 25% of our consolidated revenues for each of the six months ended June 30, 2016 and 2015. Including 100% of the revenues generated at the unconsolidated LLCs in which we have various non-controlling equity interests ranging from 33% to 95%, the leases on the UHS hospital facilities accounted for approximately 20% of the combined consolidated and unconsolidated revenue for each of the three and six months ended June 30, 2016 and 2015. In addition, we have seventeen medical office buildings (“MOBs”), including one currently under construction, or free-standing emergency departments (“FEDs”), that are either wholly or jointly-owned by us, and include or will include tenants which are subsidiaries of UHS. Pursuant to the Master Lease Document by and among us and certain subsidiaries of UHS, dated December 24, 1986 (the “Master Lease”), which governs the leases of all hospital properties with subsidiaries of UHS, UHS has the option to renew the leases at the lease terms described below by providing notice to us at least 90 days prior to the termination of the then current term. UHS also has the right to purchase the respective leased facilities at the end of the lease terms or any renewal terms at the appraised fair market value. In addition, the Master Lease, as amended during 2006, includes a change of control provision whereby UHS has the right, upon one month’s notice should a change of control of the Trust occur, to purchase any or all of the three leased hospital properties listed below at their appraised fair market value. Additionally, UHS has rights of first refusal to: (i) purchase the respective leased facilities during and for 180 days after the lease terms at the same price, terms and conditions of any third-party offer, or; (ii) renew the lease on the respective leased facility at the end of, and for 180 days after, the lease term at the same terms and conditions pursuant to any third-party offer. In June, 2016, three wholly-owned subsidiaries of UHS provided the required notice to us, exercising the 5-year renewal options on the leases related to our acute care hospitals noted in the table below. The renewals extended the lease terms on these facilities, at existing lease rates, to December, 2021. The table below details the existing lease terms and renewal options for our three acute care hospitals operated by wholly-owned subsidiaries of UHS: Hospital Name Annual Minimum Rent End of Lease Term Renewal Term (years) McAllen Medical Center $ 5,485,000 December, 2021 10 (a) Wellington Regional Medical Center $ 3,030,000 December, 2021 10 (b) Southwest Healthcare System, Inland Valley Campus $ 2,648,000 December, 2021 10 (b) (a) UHS has two 5-year renewal options at existing lease rates (through 2031). (b) UHS has two 5-year renewal options at fair market value lease rates (2022 through 2031). Management cannot predict whether the leases with subsidiaries of UHS, which have renewal options at existing lease rates or fair market value lease rates, or any of our other leases, will be renewed at the end of their lease term. If the leases are not renewed at their current rates or the fair market value lease rates, we would be required to find other operators for those facilities and/or enter into leases on terms potentially less favorable to us than the current leases. In addition, if subsidiaries of UHS exercise their options to purchase the respective leased hospital and FED facilities upon expiration of the lease terms, our future revenues could decrease if we were unable to earn a favorable rate of return on the sale proceeds received, as compared to the rental revenue currently earned pursuant to the these leases. During the first quarter of 2016, we committed to invest up to $21.1 million in the development and construction of the Henderson Medical Plaza, an MOB located on the campus of the Henderson Hospital Medical Center which is owned by a UHS subsidiary and also currently under construction. We have invested $1.5 million in this MOB as of June 30, 2016. The hospital and MOB are both scheduled to be completed and opened during the fourth quarter of 2016. Advisory Agreement: UHS of Delaware, Inc. (the “Advisor”), a wholly-owned subsidiary of UHS, serves as Advisor to us under an Advisory Agreement (the “Advisory Agreement”) dated December 24, 1986. Pursuant to the Advisory Agreement, the Advisor is obligated to present an investment program to us, to use its best efforts to obtain investments suitable for such program (although it is not obligated to present any particular investment opportunity to us), to provide administrative services to us and to conduct our day-to-day affairs. All transactions between us and UHS must be approved by the Trustees who are unaffiliated with UHS (the “Independent Trustees”). In performing its services under the Advisory Agreement, the Advisor may utilize independent professional services, including accounting, legal, tax and other services, for which the Advisor is reimbursed directly by us. The Advisory Agreement may be terminated for any reason upon sixty days written notice by us or the Advisor. The Advisory Agreement expires on December 31 of each year; however, it is renewable by us, subject to a determination by the Independent Trustees, that the Advisor’s performance has been satisfactory. In December of 2015, based upon a review of our advisory fee and other general and administrative expenses, as compared to an industry peer group, the Advisory agreement was renewed for 2016 pursuant to the same terms as the Advisory Agreement in place during 2015. The average real estate assets for advisory fee calculation purposes exclude certain items from our consolidated balance sheet such as, among other things, accumulated depreciation, cash and cash equivalents, base and bonus rent receivables, deferred charges and other assets. The advisory fee is payable quarterly, subject to adjustment at year-end based upon our audited financial statements. In addition, the Advisor is entitled to an annual incentive fee equal to 20% of the amount by which cash available for distribution to shareholders for each year, as defined in the Advisory Agreement, exceeds 15% of our equity as shown on our consolidated balance sheet, determined in accordance with generally accepted accounting principles without reduction for return of capital dividends. The Advisory Agreement defines cash available for distribution to shareholders as net cash flow from operations less deductions for, among other things, amounts required to discharge our debt and liabilities and reserves for replacement and capital improvements to our properties and investments. No incentive fees were paid during the first six months of 2016 or 2015 since the incentive fee requirements were not achieved. Advisory fees incurred and paid (or payable) to UHS amounted to $781,000 and $693,000 for the three months ended June 30, 2016 and 2015, respectively, and were based upon average invested real estate assets of $446 million and $396 million for the three-month periods ended June 30, 2016 and 2015, respectively. Advisory fees incurred and paid (or payable) to UHS amounted to $1.5 million and $1.4 million for the six months ended June 30, 2016 and 2015, respectively, and were based upon average invested real estate assets of $442 million and $388 million for the six-month periods ended June 30, 2016 and 2015, respectively. Officers and Employees: Our officers are all employees of a wholly-owned subsidiary of UHS and although as of June 30, 2016 we had no salaried employees, our officers do typically receive annual stock-based compensation awards in the form of restricted stock. In special circumstances, if warranted and deemed appropriate by the Compensation Committee of the Board of Trustees, our officers may also receive one-time special compensation awards in the form of restricted stock and/or cash bonuses. Share Ownership: As of June 30, 2016 and December 31, 2015, UHS owned 5.8% and 5.9%, respectively, of our outstanding shares of beneficial interest. SEC reporting requirements of UHS: UHS is subject to the reporting requirements of the SEC and is required to file annual reports containing audited financial information and quarterly reports containing unaudited financial information. Since the leases on the hospital facilities leased to wholly-owned subsidiaries of UHS comprised approximately 24% and 25% of our consolidated revenues during the three month periods ended June 30, 2016 and 2015, respectively, and comprised approximately 25% of our consolidated revenues during each of the six months ended June 30, 2016 and 2015, and since a subsidiary of UHS is our Advisor, you are encouraged to obtain the publicly available filings for Universal Health Services, Inc. from the SEC’s website. These filings are the sole responsibility of UHS and are not incorporated by reference herein.

Dividends and Equity Issuance P

Dividends and Equity Issuance Program	6 Months Ended
	Jun. 30, 2016
Equity [Abstract]
Dividends and Equity Issuance Program	(3) Dividends and Equity Issuance Program Dividends: We declared and paid dividends of $8.8 million, or $.65 per share, during the second quarter of 2016 and $8.5 million, or $.64 per share, during the second quarter of 2015. We declared and paid dividends of $17.4 million, or $1.295 per share, during the six-month period ended June 30, 2016 and $17.0 million, or $1.275 per share, during the six-month period ended June 30, 2015. Equity Issuance Program: During the second quarter of 2016, we recommenced our at-the-market (“ATM”) equity issuance program, pursuant to the terms of which we may sell, from time-to-time, common shares of our beneficial interest up to an aggregate sales price of approximately $23.3 million to or through Merrill Lynch, Pierce, Fenner and Smith, Incorporated (“Merrill Lynch”), as sales agent and/or principal. The common shares were offered pursuant to the Registration Statement filed with the Securities and Exchange Commission, which became effective during the fourth quarter of 2015. During the second quarter of 2016, there were 249,016 shares issued pursuant to the ATM program at an average price of $55.30 per share, which generated approximately $13.2 million of cash net proceeds or receivables (net of approximately $558,000, consisting of compensation of $344,000 to Merrill Lynch, as well as $214,000 of other various fees and expenses). Since inception of this ATM program, we have issued 829,916 shares at an average price of $48.77 per share, which generated approximately $38.8 million of net proceeds or receivables (net of approximately $1.7 million, consisting of compensation of $1.0 million to Merrill Lynch as well as $680,000 of other various fees and expenses). Included in the net ATM proceeds mentioned above is approximately $1.1 million of net proceeds due to us in connection with shares issued in late June, 2016. The net cash proceeds related to these shares were received by us in early July, 2016.

Acquisitions, Dispositions and

Acquisitions, Dispositions and New Construction	6 Months Ended
	Jun. 30, 2016
Business Combinations [Abstract]
Acquisitions, Dispositions and New Construction	(4) Acquisitions, Dispositions and New Construction Six Months Ended June 30, 2016: Acquisition: In June, 2016, we purchased the Chandler Corporate Center III located in Chandler, Arizona, for a net purchase price of approximately $18.0 million. The property, which consists of 82,000 rentable square feet, is currently 92% occupied by one tenant pursuant to the terms of a twelve year escalating triple-net lease, with a ten year fair-market value renewal option that is guaranteed by the tenant. The lease had a remaining lease term of approximately 11.3 years at the time of acquisition. The aggregate purchase price for this MOB was preliminarily allocated to the assets acquired and liabilities assumed consisting of tangible property and intangible assets, based on the fair value estimated at acquisition as detailed in the table below. The actual allocation of the total purchase price will be recorded during the third quarter of 2016, subject to a third-party appraisal and will be based upon the fair value at acquisition. The intangible assets will be amortized over the average remaining lease term of approximately 11.3 years at the time of acquisition. The estimated allocation is as follows: Land $1,980 Buildings and improvements 13,709 Intangible assets 2,344 Net cash paid $18,033 In March, 2016, we purchased the Madison Professional Office Building located in Madison, Alabama for approximately $10.1 million. This multi-tenant property consists of approximately 30,100 rentable square feet and is fully occupied with an average remaining lease term of approximately 6.2 years at the time of acquisition. The aggregate purchase price for this MOB was allocated to the assets acquired and liabilities assumed consisting of tangible property and identified intangible assets, based on the fair value estimated at acquisition as detailed in the table below. Substantially all of the intangible assets include the value of the in-place leases at the MOB at the time of acquisition which will be amortized over the average remaining lease term of approximately 6.2 years at the time of acquisition. Land $2,296 Buildings and improvements 6,411 Intangible assets 1,353 Deposit (150) Net cash paid $9,910 New Construction: During the first quarter of 2016, we committed to invest up to $21.1 million in the development and construction of the Henderson Medical Plaza, an MOB located on the campus of the Henderson Hospital Medical Center which is owned by a UHS subsidiary and also currently under construction. We have invested $1.5 million on the development and construction for this MOB as of June 30, 2016. The hospital and MOB are both scheduled to be completed and opened during the fourth quarter of 2016. Dispositions: There were no divestitures during the first six months of 2016. Six Months Ended June 30, 2015: Property Exchange Transaction: In May, 2015, in exchange for the real property of Sheffield Medical Building (“Sheffield”), a 73,446 square foot medical office building (“MOB”) located in Atlanta, Georgia, we received $2 million in cash and the real property of two MOBs located in Sandy Springs and Vinings, Georgia, from an unrelated third party. In connection with the two MOBs acquired in this transaction, triple net, master lease agreements applicable to 100% of the combined 36,700 rentable square feet of these properties were executed with the counterparty. These master lease agreements have initial terms of 15 years and provide for 3% annual rent increases. We recorded an $8.7 million gain which is included in our Condensed Consolidated Statements of Income for the three and six-months ended June 30, 2015, representing the difference between recorded net book value of Sheffield and the fair values of the properties exchanged, combined with the cash proceeds received. Acquisitions: In February, 2015, we purchased the Haas Medical Office Park, two single story buildings having an aggregate of approximately 16,000 rentable square feet, located in Ottumwa, Iowa, for approximately $4.1 million. In January and February of 2015, we purchased from wholly-owned subsidiaries of UHS, the real property of two newly-constructed and recently opened FEDs located in Weslaco and Mission, Texas, for an aggregate acquisition cost of approximately $12.8 million. Each FED consists of approximately 13,600 square feet and is operated by wholly-owned subsidiaries of UHS. In connection with these acquisitions, ten-year lease agreements with six 5-year renewal terms were executed with UHS for each FED. In connection with the lease agreements, the lessee shall have the option to purchase the leased property upon the expiration of the fixed term and each five-year extended term at the fair market value at that time. Dispositions: There were no divestitures during the first six months of 2015.

Summarized Financial Informatio

Summarized Financial Information of Equity Affiliates	6 Months Ended
	Jun. 30, 2016
Equity Method Investments And Joint Ventures [Abstract]
Summarized Financial Information of Equity Affiliates	(5) Summarized Financial Information of Equity Affiliates In accordance with the Financial Accounting Standards Board’s (“FASB”) standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs/LPs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i) divestiture of property; (ii) annual budget approval, and; (iii) financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied. At June 30, 2016, we have non-controlling equity investments or commitments in five jointly-owned LLCs/LPs which own MOBs. As of June 30, 2016, we accounted for these LLCs/LPs on an unconsolidated basis pursuant to the equity method since they are not variable interest entities and we do not have a controlling voting interest. The majority of these entities are joint-ventures between us and non-related parties that manage and hold minority ownership interests in the entities. Each entity is generally self-sustained from a cash flow perspective and generates sufficient cash flow to meet its operating cash flow requirements and service the third-party debt (if applicable) that is non-recourse to us. Although there is typically no ongoing financial support required from us to these entities since they are cash-flow sufficient, we may, from time to time, provide funding for certain purposes such as, but not limited to, significant capital expenditures, leasehold improvements and debt financing. Although we are not obligated to do so, if approved by us at our sole discretion, additional cash fundings are typically advanced as equity or member loans. These entities maintain property insurance on the properties. Effective February 1, 2016, we purchased an additional 10% ownership interest in the Arlington Medical Properties, LLC from the third-party minority member, subject to certain agreed upon terms and conditions. Including this additional ownership interest, we currently own 85% of this LLC which is accounted for on an unconsolidated basis pursuant to the equity method. The following property table represents the five LLCs in which we own a noncontrolling interest and were accounted for under the equity method as of June 30, 2016: Name of LLC/LP Ownership Property Owned by LLC Suburban Properties 33 % St. Matthews Medical Plaza II Brunswick Associates (a.) 74 % Mid Coast Hospital MOB Arlington Medical Properties (b.) 85 % Saint Mary’s Professional Office Building Grayson Properties (c.) 95 % Texoma Medical Plaza FTX MOB Phase II (d.) 95 % Forney Medical Plaza II (a.) This LLC has a third-party term loan, which is non-recourse to us, of $8.7 million outstanding as of June 30, 2016. (b.) We have funded $5.2 million in equity as of June 30, 2016 and are committed to invest an additional $623,000. During the fourth quarter of 2015, we advanced this LLC a member loan, the funds of which were utilized to repay its $22.8 million outstanding third-party mortgage loan on its scheduled maturity date. The terms of the member loan are similar to those in place pursuant to the third-party mortgage loan that was repaid. Additionally, pursuant to the terms and conditions of an agreement executed in February, 2016, we purchased an additional 10% of the ownership interest in this LLC from the existing third-party member for approximately $4.8 million in cash, thereby increasing our ownership interest to 85%. (c.) We have funded $2.8 million in equity as of June 30, 2016, and are committed to fund an additional $100,000. This building is on the campus of a UHS hospital and has tenants that include subsidiaries of UHS. This LLC has a third-party term loan, which is non-recourse to us, of $14.6 million outstanding as of June 30, 2016. (d.) We have committed to invest up to $2.5 million in equity and debt financing, of which $2.1 million has been funded as of June 30, 2016. This LLC has a third-party term loan, which is non-recourse to us, of $5.4 million outstanding as of June 30, 2016. Below are the condensed combined statements of income (unaudited) for the LLCs accounted for under the equity method at June 30, 2016 and 2015. Three Months Ended June 30, Six Months Ended June 30, 2016 2015 2016 2015 (amounts in thousands) (amounts in thousands) Revenues $ 3,925 $ 3,576 $ 7,661 $ 7,161 Operating expenses 1,343 1,396 2,696 2,733 Depreciation and amortization 651 574 1,264 1,154 Interest, net 635 632 1,292 1,251 Net income $ 1,296 $ 974 $ 2,409 $ 2,023 Our share of net income (a.) $ 1,227 $ 673 $ 2,286 $ 1,265 (a.) Our share of net income for the three and six months ended June 30, 2016 includes approximately $293,000 and $589,000, respectively, of interest income earned by us on an advance made to Arlington Medical Properties, LLC (advance balance payable to us is approximately $22.1 million as of June 30, 2016). There were no advances outstanding during the first six months of 2015, therefore there was no interest income earned by us for the three and six months ended June 30, 2015. Also, as mentioned above, effective February 1, 2016, we purchased an additional 10% of the ownership interest in Arlington Medical Properties, LLC thereby increasing our ownership interest to 85%, from 75% previously. Below are the condensed combined balance sheets (unaudited) for the five above-mentioned LLCs in which we hold noncontrolling ownership interests and that were accounted for under the equity method as of June 30, 2016 and December 31, 2015: June 30, 2016 December 31, 2015 (amounts in thousands) Net property, including CIP $ 61,948 $ 61,668 Other assets 5,439 5,264 Total assets $ 67,387 $ 66,932 Liabilities $ 2,971 $ 2,538 Mortgage notes payable, non-recourse to us 28,629 28,895 Advances payable to us 22,069 22,489 Equity 13,718 13,010 Total liabilities and equity $ 67,387 $ 66,932 Our share of equity in and advances to LLCs reflected as: Investments in LLCs (a.) $ 14,802 $ 9,108 Advances to LLCs 22,069 22,489 Investments in and advances to LLCs before amounts included in accrued expenses and other liabilities 36,871 31,597 Amounts included in accrued expenses and other liabilities (1,448 ) (1,105 ) Our share of equity in and advances to LLCs, net $ 35,423 $ 30,492 (a.) As mentioned above, effective February 1, 2016, we purchased an additional 10% of the ownership interest in Arlington Medical Properties, LLC thereby increasing our ownership interest to 85%, from 75% in 2015. As of June 30, 2016, and December 31, 2015, aggregate principal amounts due on mortgage notes payable by unconsolidated LLCs, which are accounted for under the equity method and are non-recourse to us, are as follows (amounts in thousands): Mortgage Loan Balance (a.) Name of LLC/LP 6/30/2016 12/31/2015 Maturity Date FTX MOB Phase II $ 5,364 $ 5,427 August, 2017 Grayson Properties 14,554 14,670 September, 2021 Brunswick Associates 8,711 8,798 December, 2024 $ 28,629 $ 28,895 (a.) All mortgage loans require monthly principal payments through maturity and include a balloon principal payment upon maturity. Pursuant to the operating and/or partnership agreements of the five LLCs/LPs in which we continue to hold non-controlling ownership interests, the third-party member and/or the Trust, at any time, potentially subject to certain conditions, have the right to make an offer (“Offering Member”) to the other member(s) (“Non-Offering Member”) in which it either agrees to: (i) sell the entire ownership interest of the Offering Member to the Non-Offering Member (“Offer to Sell”) at a price as determined by the Offering Member (“Transfer Price”), or; (ii) purchase the entire ownership interest of the Non-Offering Member (“Offer to Purchase”) at the equivalent proportionate Transfer Price. The Non-Offering Member has 60 to 90 days to either: (i) purchase the entire ownership interest of the Offering Member at the Transfer Price, or; (ii) sell its entire ownership interest to the Offering Member at the equivalent proportionate Transfer Price. The closing of the transfer must occur within 60 to 90 days of the acceptance by the Non-Offering Member.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	6 Months Ended
	Jun. 30, 2016
New Accounting Pronouncements And Changes In Accounting Principles [Abstract]
Recent Accounting Pronouncements	(6) Recent Accounting Pronouncements In February 2016, the Financial Accounting Standards Board (“FASB”) In April 2015, the FASB issued ASU No. 2015-03, Simplifying the Presentation of Debt Issuance Costs, an update to the accounting standard relating to the presentation of debt issuance costs. Under the new guidance, debt issuance costs related to a recognized debt liability will be presented on the balance sheet as a direct deduction from the debt liability. In the event that there is not an associated debt liability recorded in the consolidated financial statements, the debt issuance costs will continue to be recorded on the consolidated balance sheet as an asset until the debt liability is recorded. The new standard became effective for the Trust on January 1, 2016. The adoption of this guidance did not have a material impact on our consolidated financial position or results of operations as the update only related to changes in financial statement presentation. In February 2015, the FASB issued ASU No. 2015-02, Consolidation – Amendments to the Consolidation Analysis, which amends the current consolidation guidance affecting both the variable interest entity (“VIE”) and voting interest entity (“VOE”) consolidation models. The standard does not add or remove any of the characteristics in determining if an entity is a VIE or VOE, but rather enhances the way the Company assesses some of these characteristics. The new standard became effective for the Trust on January 1, 2016 and did not have a material impact on our consolidated financial position or results of operations as none of its existing consolidation conclusions were changed.

Debt and Financial Instruments

Debt and Financial Instruments	6 Months Ended
	Jun. 30, 2016
Debt Disclosure [Abstract]
Debt and Financial Instruments	(7) Debt and Financial Instruments Debt: Management routinely monitors and analyzes the Trust’s capital structure in an effort to maintain the targeted balance among capital resources including the level of borrowings pursuant to our $250 million revolving credit facility, the level of borrowings pursuant to non-course mortgage debt secured by the real property of our properties and our level of equity including consideration of additional equity issuances pursuant to our ATM equity issuance program. This ongoing analysis considers factors such as the current debt market and interest rate environment, the current/projected occupancy and financial performance of our properties, the current loan-to-value ratio of our properties, the Trust’s current stock price, the capital resources required for anticipated acquisitions and the expected capital to be generated by anticipated divestitures. This analysis, together with consideration of the Trust’s current balance of revolving credit facility borrowings, non-recourse mortgage borrowings and equity, assists management in deciding which capital resource to utilize when events such as refinancing of specific debt components occur or additional funds are required to finance the Trust’s growth. On March 27, 2015, we entered into a $185 million revolving credit agreement (“Credit Agreement”) which was amended on May 24, 2016 to, among other things, increase the borrowing capacity to $250 million. The amended Credit Agreement, which is scheduled to mature in March, 2019, includes a $40 million sub limit for letters of credit and a $20 million sub limit for swingline/short-term loans. The Credit Agreement also provides a one-time option to extend the maturity date for an additional one year period, and an option to increase the total facility borrowing capacity up to an additional $50 million, subject to lender agreement. Borrowings under the Credit Agreement are guaranteed by certain subsidiaries of the Trust. In addition, borrowings under the Credit Agreement are secured by first priority security interests in and liens on all equity interests in the Trust’s wholly-owned subsidiaries. Borrowings made pursuant to the Credit Agreement will bear interest, at our option, at one, two, three, or six month LIBOR plus an applicable margin ranging from 1.50% to 2.00% or at the Base Rate plus an applicable margin ranging from 0.50% to 1.00%. The Credit Agreement defines “Base Rate” as the greatest of: (a) the administrative agent’s prime rate; (b) the federal funds effective rate plus 1/2 of 1%, and; (c) one month LIBOR plus 1%. A commitment fee of 0.20% to 0.40% (depending on our total leverage ratio) will be charged on the average unused portion of the revolving credit commitments. The margins over LIBOR, Base Rate and the commitment fee are based upon our ratio of debt to total capital. At June 30, 2016, the applicable margin over the LIBOR rate was 1.625%, the margin over the Base Rate was 0.625%, and the commitment fee was 0.25%. At June 30, 2016, we had $167.0 million of outstanding borrowings and $3.0 million of letters of credit outstanding under our Credit Agreement. We had $80.0 million of available borrowing capacity, net of the outstanding borrowings and letters of credit outstanding as of June 30, 2016. At December 31, 2015, we had $142.2 million of outstanding borrowings and $3.5 million of letters of credit outstanding against our r Credit Agreement. We had $39.3 million of available borrowing capacity, net of the outstanding borrowings and letters of credit outstanding as of December 31, 2015. There are no compensating balance requirements. The Credit Agreement contains customary affirmative and negative covenants, including limitations on certain indebtedness, liens, acquisitions and other investments, fundamental changes, asset dispositions and dividends and other distributions. The Credit Agreement also contains restrictive covenants regarding the Trust’s ratio of total debt to total assets, the fixed charge coverage ratio, the ratio of total secured debt to total asset value, the ratio of total unsecured debt to total unencumbered asset value, and minimum tangible net worth, as well as customary events of default, the occurrence of which may trigger an acceleration of amounts outstanding under the Credit Agreement. We are in compliance with all of the covenants at June 30, 2016. We also believe that we would remain in compliance if the full amount of our commitment was borrowed. The following table includes a summary of the required compliance ratios, giving effect to the covenants contained in the Credit Agreement (dollar amounts in thousands): Covenant June 30, 2016 Tangible net worth $ 125,000 $ 179,215 Total leverage < 60% 46.2 % Secured leverage < 30% 18.5 % Unencumbered leverage < 60% 45.7 % Fixed charge coverage > 1.50x 3.6x As indicated on the following table, we have fourteen mortgages, all of which are non-recourse to us, included on our condensed consolidated balance sheet as of June 30, 2016, with a combined outstanding balance of $108.7 million, excluding net debt premium of $188,000 and net of net financing fees of $348,000 (amounts in thousands): Facility Name Outstanding Balance (in Interest Rate Maturity Date Summerlin Hospital Medical Office Building III floating rate mortgage loan (b.) $ 10,538 3.72 % December, 2016 Peace Health fixed rate mortgage loan (b.) 20,553 5.64 % April, 2017 Auburn Medical II floating rate mortgage loan (b.) 6,840 3.21 % April, 2017 Medical Center of Western Connecticut fixed rate mortgage loan (b.) 4,600 6.00 % June, 2017 Summerlin Hospital Medical Office Building II fixed rate mortgage loan 11,257 5.50 % October, 2017 Phoenix Children’s East Valley Care Center fixed rate mortgage loan 6,276 5.88 % December, 2017 Centennial Hills Medical Office Building floating rate mortgage loan 10,191 3.72 % January, 2018 Sparks Medical Building/Vista Medical Terrace floating rate mortgage loan 4,290 3.72 % February, 2018 Rosenberg Children’s Medical Plaza fixed rate mortgage loan 8,233 4.85 % May, 2018 Vibra Hospital-Corpus Christi fixed rate mortgage loan 2,770 6.50 % July, 2019 700 Shadow Lane and Goldring MOBs fixed rate mortgage loan 6,339 4.54 % June, 2022 BRB Medical Office Building fixed rate mortgage loan 6,408 4.27 % December, 2022 Desert Valley Medical Center fixed rate mortgage loan 5,146 3.62 % January, 2023 Tuscan Professional Building fixed rate mortgage loan 5,219 5.56 % June, 2025 Total $ 108,660 (a.) All mortgage loans require monthly principal payments through maturity and either fully amortize or include a balloon principal payment upon maturity. (b.) This loan is scheduled to mature within the next twelve months, at which time we will decide whether to refinance pursuant to a new mortgage loan or by utilizing borrowings under our Credit Agreement. The mortgages are secured by the real property of the buildings as well as property leases and rents. The mortgages have a combined fair value of approximately $111 million as of June 30, 2016. Changes in market rates on our fixed rate debt impacts the fair value of debt, but it has no impact on interest incurred or cash flow. At December 31, 2015, we had fourteen mortgages, all of which were non-recourse to us, included in our consolidated balance sheet. The combined outstanding balance of these fourteen mortgages was $110.3 million (excluding net debt premium of $298,000 and net of net financing fees of $398,000), and had a combined fair value of approximately $112.4 million. Financial Instruments: During the third quarter of 2013, we entered into an interest rate cap on a total notional amount of $10 million whereby we paid a premium of $136,000. During the first quarter of 2014, we entered into two additional interest rate cap agreements on a total notional amount of $20 million whereby we paid premiums of $134,500. In exchange for the premium payments, the counterparties agreed to pay us the difference between 1.50% and one-month LIBOR if one-month LIBOR rises above 1.50% during the term of the cap. From inception through June 30, 2016, no payments have been made to us by the counterparties pursuant to the terms of these caps which expire in January, 2017. During the second quarter of 2016, we entered into an interest rate cap on the total notional amount of $30 million whereby we paid a premium of $115,000. In exchange for the premium payment, the counterparties agreed to pay us the difference between 1.50% and one-month LIBOR if one-month LIBOR rises above 1.50% during the term of the cap. This interest rate cap becomes effective in January, 2017, coinciding with the expiration of the above-mentioned interest rate caps.

Segment Reporting

Segment Reporting	6 Months Ended
	Jun. 30, 2016
Segment Reporting [Abstract]
Segment Reporting	(8) Segment Reporting Our primary business is investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. We actively manage our portfolio of healthcare and human service facilities and may from time to time make decisions to sell lower performing properties not meeting our long-term investment objectives. The proceeds of sales are typically reinvested in new developments or acquisitions, which we believe will meet our planned rate of return. It is our intent that all healthcare and human service facilities will be owned or developed for investment purposes. Our revenue and net income are generated from the operation of our investment portfolio. Our portfolio is located throughout the United States, however, we do not distinguish or group our operations on a geographical basis for purposes of allocating resources or measuring performance. We review operating and financial data for each property on an individual basis; therefore, we define an operating segment as our individual properties. Individual properties have been aggregated into one reportable segment based upon their similarities with regard to both the nature and economics of the facilities, tenants and operational processes, as well as long-term average financial performance.

Relationship with Universal H15

Relationship with Universal Health Services, Inc. ("UHS") and Related Party Transactions (Tables)	6 Months Ended
	Jun. 30, 2016
Related Party Transactions [Abstract]
Existing Lease Terms and Renewal Options for Each of UHS Hospital Facilities	The table below details the existing lease terms and renewal options for our three acute care hospitals operated by wholly-owned subsidiaries of UHS: Hospital Name Annual Minimum Rent End of Lease Term Renewal Term (years) McAllen Medical Center $ 5,485,000 December, 2021 10 (a) Wellington Regional Medical Center $ 3,030,000 December, 2021 10 (b) Southwest Healthcare System, Inland Valley Campus $ 2,648,000 December, 2021 10 (b) (a) UHS has two 5-year renewal options at existing lease rates (through 2031). (b) UHS has two 5-year renewal options at fair market value lease rates (2022 through 2031).

Acquisitions, Dispositions an16

Acquisitions, Dispositions and New Construction (Tables)	6 Months Ended
	Jun. 30, 2016
Business Combinations [Abstract]
Allocation of Purchase Price to Assets Acquired and Liabilities Assumed	The aggregate purchase price for this MOB was preliminarily allocated to the assets acquired and liabilities assumed consisting of tangible property and intangible assets, based on the fair value estimated at acquisition as detailed in the table below. The actual allocation of the total purchase price will be recorded during the third quarter of 2016, subject to a third-party appraisal and will be based upon the fair value at acquisition. The intangible assets will be amortized over the average remaining lease term of approximately 11.3 years at the time of acquisition. The estimated allocation is as follows: Land $1,980 Buildings and improvements 13,709 Intangible assets 2,344 Net cash paid $18,033 The aggregate purchase price for this MOB was allocated to the assets acquired and liabilities assumed consisting of tangible property and identified intangible assets, based on the fair value estimated at acquisition as detailed in the table below. Substantially all of the intangible assets include the value of the in-place leases at the MOB at the time of acquisition which will be amortized over the average remaining lease term of approximately 6.2 years at the time of acquisition. Land $2,296 Buildings and improvements 6,411 Intangible assets 1,353 Deposit (150) Net cash paid $9,910

Summarized Financial Informat17

Summarized Financial Information of Equity Affiliates (Tables)	6 Months Ended
	Jun. 30, 2016
Equity Method Investments And Joint Ventures [Abstract]
Limited Liability Companies Accounted for Under Equity Method	The following property table represents the five LLCs in which we own a noncontrolling interest and were accounted for under the equity method as of June 30, 2016: Name of LLC/LP Ownership Property Owned by LLC Suburban Properties 33 % St. Matthews Medical Plaza II Brunswick Associates (a.) 74 % Mid Coast Hospital MOB Arlington Medical Properties (b.) 85 % Saint Mary’s Professional Office Building Grayson Properties (c.) 95 % Texoma Medical Plaza FTX MOB Phase II (d.) 95 % Forney Medical Plaza II (a.) This LLC has a third-party term loan, which is non-recourse to us, of $8.7 million outstanding as of June 30, 2016. (b.) We have funded $5.2 million in equity as of June 30, 2016 and are committed to invest an additional $623,000. During the fourth quarter of 2015, we advanced this LLC a member loan, the funds of which were utilized to repay its $22.8 million outstanding third-party mortgage loan on its scheduled maturity date. The terms of the member loan are similar to those in place pursuant to the third-party mortgage loan that was repaid. Additionally, pursuant to the terms and conditions of an agreement executed in February, 2016, we purchased an additional 10% of the ownership interest in this LLC from the existing third-party member for approximately $4.8 million in cash, thereby increasing our ownership interest to 85%. (c.) We have funded $2.8 million in equity as of June 30, 2016, and are committed to fund an additional $100,000. This building is on the campus of a UHS hospital and has tenants that include subsidiaries of UHS. This LLC has a third-party term loan, which is non-recourse to us, of $14.6 million outstanding as of June 30, 2016. (d.) We have committed to invest up to $2.5 million in equity and debt financing, of which $2.1 million has been funded as of June 30, 2016. This LLC has a third-party term loan, which is non-recourse to us, of $5.4 million outstanding as of June 30, 2016.
Condensed Combined Statements of Income (Unaudited) for Limited Liability Companies Accounted for Under Equity Method	Below are the condensed combined statements of income (unaudited) for the LLCs accounted for under the equity method at June 30, 2016 and 2015. Three Months Ended June 30, Six Months Ended June 30, 2016 2015 2016 2015 (amounts in thousands) (amounts in thousands) Revenues $ 3,925 $ 3,576 $ 7,661 $ 7,161 Operating expenses 1,343 1,396 2,696 2,733 Depreciation and amortization 651 574 1,264 1,154 Interest, net 635 632 1,292 1,251 Net income $ 1,296 $ 974 $ 2,409 $ 2,023 Our share of net income (a.) $ 1,227 $ 673 $ 2,286 $ 1,265 (a.) Our share of net income for the three and six months ended June 30, 2016 includes approximately $293,000 and $589,000, respectively, of interest income earned by us on an advance made to Arlington Medical Properties, LLC (advance balance payable to us is approximately $22.1 million as of June 30, 2016). There were no advances outstanding during the first six months of 2015, therefore there was no interest income earned by us for the three and six months ended June 30, 2015. Also, as mentioned above, effective February 1, 2016, we purchased an additional 10% of the ownership interest in Arlington Medical Properties, LLC thereby increasing our ownership interest to 85%, from 75% previously.
Condensed Combined Balance Sheets (Unaudited) for LLCs Accounted for Under Equity Method	Below are the condensed combined balance sheets (unaudited) for the five above-mentioned LLCs in which we hold noncontrolling ownership interests and that were accounted for under the equity method as of June 30, 2016 and December 31, 2015: June 30, 2016 December 31, 2015 (amounts in thousands) Net property, including CIP $ 61,948 $ 61,668 Other assets 5,439 5,264 Total assets $ 67,387 $ 66,932 Liabilities $ 2,971 $ 2,538 Mortgage notes payable, non-recourse to us 28,629 28,895 Advances payable to us 22,069 22,489 Equity 13,718 13,010 Total liabilities and equity $ 67,387 $ 66,932 Our share of equity in and advances to LLCs reflected as: Investments in LLCs (a.) $ 14,802 $ 9,108 Advances to LLCs 22,069 22,489 Investments in and advances to LLCs before amounts included in accrued expenses and other liabilities 36,871 31,597 Amounts included in accrued expenses and other liabilities (1,448 ) (1,105 ) Our share of equity in and advances to LLCs, net $ 35,423 $ 30,492 (a.) As mentioned above, effective February 1, 2016, we purchased an additional 10% of the ownership interest in Arlington Medical Properties, LLC thereby increasing our ownership interest to 85%, from 75% in 2015.
Aggregate Principal Amounts due on Mortgage and Construction Notes Payable by Unconsolidated LLC's Accounted Under Equity Method	As of June 30, 2016, and December 31, 2015, aggregate principal amounts due on mortgage notes payable by unconsolidated LLCs, which are accounted for under the equity method and are non-recourse to us, are as follows (amounts in thousands): Mortgage Loan Balance (a.) Name of LLC/LP 6/30/2016 12/31/2015 Maturity Date FTX MOB Phase II $ 5,364 $ 5,427 August, 2017 Grayson Properties 14,554 14,670 September, 2021 Brunswick Associates 8,711 8,798 December, 2024 $ 28,629 $ 28,895 (a.) All mortgage loans require monthly principal payments through maturity and include a balloon principal payment upon maturity.

Debt and Financial Instruments

Debt and Financial Instruments (Tables)	6 Months Ended
	Jun. 30, 2016
Debt Disclosure [Abstract]
Summary of Required Compliance Ratios Giving Effect to New Covenants in Credit Agreement	The following table includes a summary of the required compliance ratios, giving effect to the covenants contained in the Credit Agreement (dollar amounts in thousands): Covenant June 30, 2016 Tangible net worth $ 125,000 $ 179,215 Total leverage < 60% 46.2 % Secured leverage < 30% 18.5 % Unencumbered leverage < 60% 45.7 % Fixed charge coverage > 1.50x 3.6x
Outstanding Mortgages, Excluding Net Debt Premium	Facility Name Outstanding Balance (in Interest Rate Maturity Date Summerlin Hospital Medical Office Building III floating rate mortgage loan (b.) $ 10,538 3.72 % December, 2016 Peace Health fixed rate mortgage loan (b.) 20,553 5.64 % April, 2017 Auburn Medical II floating rate mortgage loan (b.) 6,840 3.21 % April, 2017 Medical Center of Western Connecticut fixed rate mortgage loan (b.) 4,600 6.00 % June, 2017 Summerlin Hospital Medical Office Building II fixed rate mortgage loan 11,257 5.50 % October, 2017 Phoenix Children’s East Valley Care Center fixed rate mortgage loan 6,276 5.88 % December, 2017 Centennial Hills Medical Office Building floating rate mortgage loan 10,191 3.72 % January, 2018 Sparks Medical Building/Vista Medical Terrace floating rate mortgage loan 4,290 3.72 % February, 2018 Rosenberg Children’s Medical Plaza fixed rate mortgage loan 8,233 4.85 % May, 2018 Vibra Hospital-Corpus Christi fixed rate mortgage loan 2,770 6.50 % July, 2019 700 Shadow Lane and Goldring MOBs fixed rate mortgage loan 6,339 4.54 % June, 2022 BRB Medical Office Building fixed rate mortgage loan 6,408 4.27 % December, 2022 Desert Valley Medical Center fixed rate mortgage loan 5,146 3.62 % January, 2023 Tuscan Professional Building fixed rate mortgage loan 5,219 5.56 % June, 2025 Total $ 108,660 (a.) All mortgage loans require monthly principal payments through maturity and either fully amortize or include a balloon principal payment upon maturity. (b.) This loan is scheduled to mature within the next twelve months, at which time we will decide whether to refinance pursuant to a new mortgage loan or by utilizing borrowings under our Credit Agreement.

General - Additional Informatio

General - Additional Information (Detail)	Jun. 30, 2016Property
5 Unconsolidated Limited Liability Companies | Minimum
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Non-controlling equity interest, ownership percentage	33.00%
5 Unconsolidated Limited Liability Companies | Maximum
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Non-controlling equity interest, ownership percentage	95.00%
Medical office buildings | Limited Liability Companies
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Number of real estate investments	5

Relationship with Universal H20

Relationship with Universal Health Services, Inc. ("UHS") and Related Party Transactions - Additional Information (Detail)	3 Months Ended		6 Months Ended
	Jun. 30, 2016USD ($)Time	Jun. 30, 2015USD ($)	Jun. 30, 2016USD ($)PropertyTimeSubsidiary	Jun. 30, 2015USD ($)	Mar. 31, 2016USD ($)	Dec. 31, 2015
Related Party Transaction [Line Items]
Maximum amount of investment for development and construction					$ 21,100,000
Advisory fee	$ 781,000	$ 693,000	$ 1,548,000	$ 1,359,000
Minimum | 5 Unconsolidated Limited Liability Companies
Related Party Transaction [Line Items]
Non-controlling equity interest, ownership percentage	33.00%		33.00%
Maximum | 5 Unconsolidated Limited Liability Companies
Related Party Transaction [Line Items]
Non-controlling equity interest, ownership percentage	95.00%		95.00%
Universal Health Services, Inc
Related Party Transaction [Line Items]
Number of term renewal options | Time	6		6
Additional renewal terms			5 years
Number of medical office buildings and free standing emergency departments | Property			17
Number of medical office buildings under construction | Property			1
Option to renew lease, notice period prior to termination date of current term			90 days
Period to purchase respective leased facilities at same price after lease terms			180 days
Renewal period of respective leased facilities at same price after lease terms			180 days
Number of wholly-owned subsidiaries | Subsidiary			3
Extended lease terms at existing lease rates			2021-12
Number of renewal options at existing lease rates | Time			3
Percentage ownership of outstanding shares	5.80%		5.80%			5.90%
Universal Health Services, Inc | Medical office buildings
Related Party Transaction [Line Items]
Amount invested in MOB under construction	$ 1,500,000		$ 1,500,000
Universal Health Services, Inc | Customer Concentration Risk | Revenues
Related Party Transaction [Line Items]
Percentage of revenues generated from leases	24.00%	25.00%	25.00%	25.00%
Universal Health Services, Inc | Customer Concentration Risk | Combined consolidated and unconsolidated revenue
Related Party Transaction [Line Items]
Percentage of revenues generated from leases	20.00%	20.00%	20.00%	20.00%
Universal Health Services, Inc | Minimum
Related Party Transaction [Line Items]
Initial lease terms			13 years
Universal Health Services, Inc | Maximum
Related Party Transaction [Line Items]
Initial lease terms			15 years
Universal Health Services of Delaware Inc
Related Party Transaction [Line Items]
Annual incentive fee to Advisor as percentage of cash available for distribution	20.00%		20.00%
Incentive fees			$ 0	$ 0
Advisory fee	$ 781,000	$ 693,000	1,500,000	1,400,000
Average invested real estate assets	$ 446,000,000	$ 396,000,000	$ 442,000,000	$ 388,000,000
Universal Health Services of Delaware Inc | Minimum
Related Party Transaction [Line Items]
Percentage of equity to be exceeded for incentive distribution	15.00%		15.00%

Existing Lease Terms and Renewa

Existing Lease Terms and Renewal Options for Each of UHS Hospital Facilities (Detail)	6 Months Ended
	Jun. 30, 2016USD ($)
McAllen Medical Center
Operating Leased Assets [Line Items]
Annual Minimum Rent	$ 5,485,000
End of Lease Term	2021-12
Renewal Term (years)	10 years	[1]
Wellington Regional Medical Center
Operating Leased Assets [Line Items]
Annual Minimum Rent	$ 3,030,000
End of Lease Term	2021-12
Renewal Term (years)	10 years	[2]
Southwest Healthcare System, Inland Valley Campus
Operating Leased Assets [Line Items]
Annual Minimum Rent	$ 2,648,000
End of Lease Term	2021-12
Renewal Term (years)	10 years	[2]
[1]	UHS has two 5-year renewal options at existing lease rates (through 2031).
[2]	UHS has two 5-year renewal options at fair market value lease rates (2022 through 2031).

Existing Lease Terms and Rene22

Existing Lease Terms and Renewal Options for Each of UHS Hospital Facilities (Parenthetical) (Detail) - Universal Health Services, Inc	6 Months Ended
	Jun. 30, 2016TimeRenewalOption
Operating Leased Assets [Line Items]
Number of renewal options at existing lease rates	3
McAllen Medical Center
Operating Leased Assets [Line Items]
Number of renewal options at existing lease rates	2
Renewal options term at existing lease rates	5 years
Renewal options at existing lease rates expiration year	2,031
Wellington Regional Medical Center And Southwest Healthcare System
Operating Leased Assets [Line Items]
Number of renewal options at fair market value lease rates | RenewalOption	2
Renewal options term at fair market value lease rates	5 years
Wellington Regional Medical Center And Southwest Healthcare System | Minimum
Operating Leased Assets [Line Items]
Renewal options at fair market value lease rates expiration year	2,022
Wellington Regional Medical Center And Southwest Healthcare System | Maximum
Operating Leased Assets [Line Items]
Renewal options at fair market value lease rates expiration year	2,031

Dividends and Equity Issuance23

Dividends and Equity Issuance Program - Additional Information (Detail) - USD ($)	1 Months Ended		3 Months Ended		6 Months Ended		33 Months Ended
	Jul. 31, 2016	Jun. 30, 2016	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016
Dividends and Equity Issuance [Line Items]
Dividends declared and paid			$ 8,800,000	$ 8,500,000	$ 17,393,000	$ 16,966,000
Declared and paid dividends, per share			$ 0.65	$ 0.64	$ 1.295	$ 1.275
Securities, aggregate sales price		$ 23,300,000	$ 23,300,000		$ 23,300,000		$ 23,300,000
At-The-Market (ATM) Equity Issuance Program
Dividends and Equity Issuance [Line Items]
Share issued			249,016				829,916
Average sale price per share					$ 55.30		$ 48.77
Net cash proceeds or receivables from stock issued					$ 13,200,000		$ 38,800,000
Payment of stock issuance cost					558,000		1,700,000
Payments for stock issuance					344,000		1,000,000
Net cash proceeds received for shares		$ 1,100,000
At-The-Market (ATM) Equity Issuance Program | Other Expense
Dividends and Equity Issuance [Line Items]
Payments for stock issuance					$ 214,000		$ 680,000
Subsequent Event | At-The-Market (ATM) Equity Issuance Program
Dividends and Equity Issuance [Line Items]
Net cash proceeds or receivables from stock issued	$ 1,100,000

Acquisitions, Dispositions an24

Acquisitions, Dispositions and New Construction - Additional Information (Detail)	1 Months Ended			2 Months Ended	3 Months Ended		6 Months Ended
	Mar. 31, 2016USD ($)ft²	May 31, 2015USD ($)ft²Property	Feb. 28, 2015USD ($)ft²TimeBuilding	Feb. 28, 2015USD ($)ft²PropertyTime	Mar. 31, 2016USD ($)ft²	Jun. 30, 2015USD ($)	Jun. 30, 2016USD ($)ft²Time	Jun. 30, 2015USD ($)
Business Acquisitions And Dispositions [Line Items]
Maximum amount of investment for development and construction	$ 21,100,000				$ 21,100,000
Cash received for property exchange transaction							$ 0	$ 2,000,000
Gain on property exchange						$ 8,742,000		8,742,000
Universal Health Services, Inc
Business Acquisitions And Dispositions [Line Items]
Number of term renewal options | Time							6
Additional renewal terms							5 years
Medical office buildings | Universal Health Services, Inc
Business Acquisitions And Dispositions [Line Items]
Amount invested in MOB under construction							$ 1,500,000
Chandler Corporate Center III
Business Acquisitions And Dispositions [Line Items]
Total purchase price							$ 18,000,000
Net rentable area | ft²							82,000
Occupied percentage of property							92.00%
Lease rent escalation period							12 years
Renewal Term (years)							11 years 3 months 18 days
Acquired intangible assets include in-place leases amortization period							11 years 3 months 18 days
Madison Professional Office Building
Business Acquisitions And Dispositions [Line Items]
Total purchase price					$ 10,100,000
Net rentable area | ft²	30,100				30,100
Renewal Term (years)	6 years 2 months 12 days
Medical office buildings
Business Acquisitions And Dispositions [Line Items]
Acquired intangible assets include in-place leases amortization period							6 years 2 months 12 days
Sheffield Medical Building Atlanta Georgia
Business Acquisitions And Dispositions [Line Items]
Net rentable area | ft²		36,700
Cash received for property exchange transaction		$ 2,000,000
Area of disposed building | ft²		73,446
Number of assets acquired | Property		2
Percentage of rentable area covered by the agreement		100.00%
Lease agreement period		15 years
Percentage of annual rent increase		3.00%
Gain on property exchange						$ 8,700,000		8,700,000
Haas Medical Office Park Ottumwa I A
Business Acquisitions And Dispositions [Line Items]
Total purchase price			$ 4,100,000
Net rentable area | ft²			16,000	16,000
Number of Buildings purchased | Building			2
Wholly Owned Subsidiaries Of U H S Real Property Of Two Newly Constructed And Recently Opened F E Ds Located In Weslaco And Mission Texas
Business Acquisitions And Dispositions [Line Items]
Total purchase price				$ 12,800,000
Cash received for property exchange transaction								$ 0
Lease agreement period				10 years
Number of real properties purchased | Property				2
Number of term renewal options | Time			6	6
Additional renewal terms				5 years
Wholly Owned Subsidiaries Of U H S Real Property Of Two Newly Constructed And Recently Opened F E Ds Located In Weslaco And Mission Texas | Recently Opened Free Standing Emergency Departments | Weslaco
Business Acquisitions And Dispositions [Line Items]
Area of acquired building | ft²			13,600	13,600
Wholly Owned Subsidiaries Of U H S Real Property Of Two Newly Constructed And Recently Opened F E Ds Located In Weslaco And Mission Texas | Recently Opened Free Standing Emergency Departments | Mission
Business Acquisitions And Dispositions [Line Items]
Area of acquired building | ft²			13,600	13,600

Allocation of Purchase Price to

Allocation of Purchase Price to Assets Acquired and Liabilities Assumed (Detail) $ in Thousands	Jun. 30, 2016USD ($)
Chandler Corporate Center III
Business Acquisition [Line Items]
Land	$ 1,980
Buildings and improvements	13,709
Intangible assets	2,344
Net cash paid	18,033
Medical office buildings
Business Acquisition [Line Items]
Land	2,296
Buildings and improvements	6,411
Intangible assets	1,353
Deposit	(150)
Net cash paid	$ 9,910

Summarized Financial Informat26

Summarized Financial Information of Equity Affiliates - Additional Information (Detail)	6 Months Ended
	Jun. 30, 2016Property
Limited Liability Companies | Medical office buildings
Schedule Of Equity Method Investments [Line Items]
Number of real estate investments	5
Minimum
Schedule Of Equity Method Investments [Line Items]
Number of days for Non-Offering Member either to purchase or sell its entire ownership interest to or from Offering Member	60 days
Maximum
Schedule Of Equity Method Investments [Line Items]
Number of days for Non-Offering Member either to purchase or sell its entire ownership interest to or from Offering Member	90 days
5 Unconsolidated Limited Liability Companies / Limited Partner | Minimum
Schedule Of Equity Method Investments [Line Items]
Non-controlling equity interest, ownership percentage	33.00%
5 Unconsolidated Limited Liability Companies / Limited Partner | Maximum
Schedule Of Equity Method Investments [Line Items]
Non-controlling equity interest, ownership percentage	95.00%
Arlington Medical Properties
Schedule Of Equity Method Investments [Line Items]
Non-controlling equity interest, ownership percentage	85.00%
Percentage of minority ownership purchased from third-party members	10.00%

Limited Liability Companies Acc

Limited Liability Companies Accounted for Under Equity Method (Detail)	6 Months Ended
	Jun. 30, 2016
Arlington Medical Properties
Schedule Of Equity Method Investments [Line Items]
Ownership	85.00%
Equity Method Investments | Suburban Properties
Schedule Of Equity Method Investments [Line Items]
Ownership	33.00%
Property Owned by LLC	St. Matthews Medical Plaza II
Equity Method Investments | Brunswick Associates
Schedule Of Equity Method Investments [Line Items]
Ownership	74.00%	[1]
Property Owned by LLC	Mid Coast Hospital MOB	[1]
Equity Method Investments | Arlington Medical Properties
Schedule Of Equity Method Investments [Line Items]
Ownership	85.00%	[2]
Property Owned by LLC	Saint Mary’s Professional Office Building	[2]
Equity Method Investments | Grayson Properties
Schedule Of Equity Method Investments [Line Items]
Ownership	95.00%	[3]
Property Owned by LLC	Texoma Medical Plaza	[3]
Equity Method Investments | FTX MOB Phase II limited partnership
Schedule Of Equity Method Investments [Line Items]
Ownership	95.00%	[4]
Property Owned by LLC	Forney Medical Plaza II	[4]
[1]	This LLC has a third-party term loan, which is non-recourse to us, of $8.7 million outstanding as of June 30, 2016.
[2]	We have funded $5.2 million in equity as of June 30, 2016 and are committed to invest an additional $623,000. During the fourth quarter of 2015, we advanced this LLC a member loan, the funds of which were utilized to repay its $22.8 million outstanding third-party mortgage loan on its scheduled maturity date. The terms of the member loan are similar to those in place pursuant to the third-party mortgage loan that was repaid. Additionally, pursuant to the terms and conditions of an agreement executed in February, 2016, we purchased an additional 10% of the ownership interest in this LLC from the existing third-party member for approximately $4.8 million in cash, thereby increasing our ownership interest to 85%.
[3]	We have funded $2.8 million in equity as of June 30, 2016, and are committed to fund an additional $100,000. This building is on the campus of a UHS hospital and has tenants that include subsidiaries of UHS. This LLC has a third-party term loan, which is non-recourse to us, of $14.6 million outstanding as of June 30, 2016.
[4]	We have committed to invest up to $2.5 million in equity and debt financing, of which $2.1 million has been funded as of June 30, 2016. This LLC has a third-party term loan, which is non-recourse to us, of $5.4 million outstanding as of June 30, 2016.

Limited Liability Companies A28

Limited Liability Companies Accounted for Under Equity Method (Parenthetical) (Detail)	6 Months Ended
	Jun. 30, 2016USD ($)
Brunswick Associates
Schedule Of Equity Method Investments [Line Items]
Third-party term loan	$ 8,700,000
Arlington Medical Properties
Schedule Of Equity Method Investments [Line Items]
Committed investment in equity and debt financing, funded	5,200,000
Commitment to investment	623,000
Proceeds from Lines of Credit	$ 22,800,000
Percentage of minority ownership purchased from third-party members	10.00%
Business acquisition additional consideration	$ 4,800,000
Cash payment made purchased addition of ownership interest	85.00%
Grayson Properties
Schedule Of Equity Method Investments [Line Items]
Third-party term loan	$ 14,600,000
Committed investment in equity and debt financing, funded	2,800,000
Commitment to investment	100,000
FTX MOB Phase II limited partnership
Schedule Of Equity Method Investments [Line Items]
Third-party term loan	5,400,000
Committed investment in equity and debt financing, funded	2,100,000
Commitment to investment	$ 2,500,000

Condensed Combined Statement of

Condensed Combined Statement of Income for Limited Liabilities Accounted for under Equity Method (Detail) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Equity Method Investments And Joint Ventures [Abstract]
Revenues		$ 3,925	$ 3,576	$ 7,661	$ 7,161
Operating expenses		1,343	1,396	2,696	2,733
Depreciation and amortization		651	574	1,264	1,154
Interest, net		635	632	1,292	1,251
Net income		1,296	974	2,409	2,023
Our share of net income	[1]	$ 1,227	$ 673	$ 2,286	$ 1,265
[1]	Our share of net income for the three and six months ended June 30, 2016 includes approximately $293,000 and $589,000, respectively, of interest income earned by us on an advance made to Arlington Medical Properties, LLC (advance balance payable to us is approximately $22.1 million as of June 30, 2016). There were no advances outstanding during the first six months of 2015, therefore there was no interest income earned by us for the three and six months ended June 30, 2015. Also, as mentioned above, effective February 1, 2016, we purchased an additional 10% of the ownership interest in Arlington Medical Properties, LLC thereby increasing our ownership interest to 85%, from 75% previously.

Condensed Combined Statement 30

Condensed Combined Statement of Income for Limited Liabilities Accounted for under Equity Method (Parenthetical) (Detail) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015	Dec. 31, 2015
Schedule Of Equity Method Investments [Line Items]
Advances payable to us	$ 22,069,000		$ 22,069,000		$ 22,489,000
Arlington Medical Properties
Schedule Of Equity Method Investments [Line Items]
Interest income earned on various advances made to LLCs	293,000	$ 0	589,000	$ 0
Advances payable to us	$ 22,100,000		$ 22,100,000
Percentage of minority ownership purchased from third-party members	10.00%		10.00%
Cash payment made purchased addition of ownership interest			85.00%		75.00%

Condensed Combined Balance Shee

Condensed Combined Balance Sheets of Limited Liabilities Accounted for under Equity Method (Detail) - USD ($) $ in Thousands		Jun. 30, 2016	Dec. 31, 2015
Equity Method Investments And Joint Ventures [Abstract]
Net property, including CIP		$ 61,948	$ 61,668
Other assets		5,439	5,264
Total assets		67,387	66,932
Liabilities		2,971	2,538
Mortgage notes payable, non-recourse to us		28,629	28,895
Advances payable to us		22,069	22,489
Equity		13,718	13,010
Total liabilities and equity		67,387	66,932
Our share of equity in and advances to LLCs reflected as:
Investments in LLCs	[1]	14,802	9,108
Advances to LLCs		22,069	22,489
Investments in and advances to LLCs before amounts included in accrued expenses and other liabilities		36,871	31,597
Amounts included in accrued expenses and other liabilities		(1,448)	(1,105)
Our share of equity in and advances to LLCs, net		$ 35,423	$ 30,492
[1]	As mentioned above, effective February 1, 2016, we purchased an additional 10% of the ownership interest in Arlington Medical Properties, LLC thereby increasing our ownership interest to 85%, from 75% in 2015.

Condensed Combined Balance Sh32

Condensed Combined Balance Sheets of Limited Liabilities Accounted for under Equity Method (Parenthetical) (Detail) - Arlington Medical Properties	6 Months Ended	12 Months Ended
	Jun. 30, 2016	Dec. 31, 2015
Schedule Of Equity Method Investments [Line Items]
Percentage of minority ownership purchased from third-party members	10.00%
Cash payment made purchased addition of ownership interest	85.00%	75.00%

Aggregate Principal Amounts Due

Aggregate Principal Amounts Due on Mortgage Notes Payable by Unconsolidated LLCs, Accounted Under Equity Method (Detail) - USD ($) $ in Thousands		6 Months Ended
		Jun. 30, 2016	Dec. 31, 2015
Schedule Of Equity Method Investments [Line Items]
Mortgage Loan Balance		$ 28,629	$ 28,895
Equity Method Investments
Schedule Of Equity Method Investments [Line Items]
Mortgage Loan Balance	[1]	28,629	28,895
Equity Method Investments | FTX MOB Phase II
Schedule Of Equity Method Investments [Line Items]
Mortgage Loan Balance	[1]	$ 5,364	5,427
Maturity Date		2017-08
Equity Method Investments | Grayson Properties
Schedule Of Equity Method Investments [Line Items]
Mortgage Loan Balance	[1]	$ 14,554	14,670
Maturity Date		2021-09
Equity Method Investments | Brunswick Associates
Schedule Of Equity Method Investments [Line Items]
Mortgage Loan Balance	[1]	$ 8,711	$ 8,798
Maturity Date		2024-12
[1]	All mortgage loans require monthly principal payments through maturity and include a balloon principal payment upon maturity.

Debt and Financial Instrument34

Debt and Financial Instruments - Additional Information (Detail)	Jun. 30, 2016USD ($)MortgageLoanDerivative		Mar. 27, 2015USD ($)Option	Jun. 30, 2016USD ($)MortgageLoanDerivative		Mar. 31, 2014USD ($)Derivative	Sep. 30, 2013USD ($)Derivative	Jun. 30, 2016USD ($)MortgageLoanDerivative		May 24, 2016USD ($)	Dec. 31, 2015USD ($)MortgageLoan
Debt Instrument [Line Items]
Outstanding borrowings under credit agreement	$ 167,000,000			$ 167,000,000				$ 167,000,000			$ 142,150,000
Outstanding borrowings under letter of credit	3,000,000			3,000,000				3,000,000			3,500,000
Available borrowing capacity	$ 80,000,000			$ 80,000,000				$ 80,000,000			$ 39,300,000
Number of non-recourse mortgages | MortgageLoan	14			14				14			14
Balance of Non Recourse Mortgages	$ 108,660,000	[1]		$ 108,660,000	[1]			$ 108,660,000	[1]		$ 110,300,000
Mortgage and other notes payable, non-recourse to us, debt premium	188,000,000			188,000,000				188,000,000			298,000
Financing fees net	348,000,000			348,000,000				348,000,000			398,000
Mortgage loan fair value	$ 111,000,000			$ 111,000,000				$ 111,000,000			$ 112,400,000
Interest Rate Cap
Debt Instrument [Line Items]
Number of interest rate cap agreements | Derivative	1			1		2	1	1
Notional amount	$ 30,000,000			$ 30,000,000		$ 20,000,000	$ 10,000,000	$ 30,000,000
Premium paid				$ 115,000		$ 134,500	$ 136,000
Expiration date of interest rate cap				Jan. 31, 2017		Jan. 31, 2017	Jan. 31, 2017
LIBOR | Interest Rate Cap
Debt Instrument [Line Items]
Derivative instruments, LIBOR rate	1.50%			1.50%		1.50%	1.50%	1.50%
Credit Agreement
Debt Instrument [Line Items]
Outstanding borrowing			$ 185,000,000							$ 250,000,000
Unsecured revolving amended credit agreement terminated date			2019-03
Number of additional one year extension options | Option			1
Proceeds from Lines of Credit			$ 50,000,000
Credit facility, Interest Rate Terms								One, two, three, or six month LIBOR plus an applicable margin ranging from 1.50% to 2.00% or at the Base Rate plus an applicable margin ranging from 0.50% to 1.00%.
Base rate description								The greatest of: (a) the administrative agent’s prime rate; (b) the federal funds effective rate plus 1/2 of 1%, and; (c) one month LIBOR plus 1%.
Fee payable on unused portion of commitment	0.25%
Credit Agreement | LIBOR
Debt Instrument [Line Items]
Margin points added to the reference rate	1.625%
Credit Agreement | Base Rate
Debt Instrument [Line Items]
Margin points added to the reference rate	0.625%
Credit Agreement | Swingline/Short-Term Loans
Debt Instrument [Line Items]
Outstanding borrowing			20,000,000
Credit Agreement | Letters of Credit
Debt Instrument [Line Items]
Outstanding borrowing			$ 40,000,000
Minimum | Credit Agreement
Debt Instrument [Line Items]
Fee payable on unused portion of commitment			0.20%
Minimum | Credit Agreement | LIBOR
Debt Instrument [Line Items]
Margin points added to the reference rate			1.50%
Margin points added to the base rate			1.00%
Minimum | Credit Agreement | Base Rate
Debt Instrument [Line Items]
Margin points added to the reference rate			0.50%
Minimum | Credit Agreement | Federal Funds Effective Rate
Debt Instrument [Line Items]
Margin points added to the base rate			0.50%
Maximum | Credit Agreement
Debt Instrument [Line Items]
Fee payable on unused portion of commitment			0.40%
Maximum | Credit Agreement | LIBOR
Debt Instrument [Line Items]
Margin points added to the reference rate			2.00%
Maximum | Credit Agreement | Base Rate
Debt Instrument [Line Items]
Margin points added to the reference rate			1.00%
[1]	All mortgage loans require monthly principal payments through maturity and either fully amortize or include a balloon principal payment upon maturity.

Summary of Required Compliance

Summary of Required Compliance Ratios in Connection with Terms of Credit Agreement (Detail) $ in Thousands	6 Months Ended
	Jun. 30, 2016USD ($)
Debt Instrument [Line Items]
Covenant, Tangible net worth	$ 125,000
Tangible net worth	$ 179,215
Total leverage	46.20%
Secured leverage	18.50%
Unencumbered leverage	45.70%
Fixed charge coverage	3.60%
Maximum
Debt Instrument [Line Items]
Covenant, Total leverage	60.00%
Covenant, Secured leverage	30.00%
Covenant, Unencumbered leverage	60.00%
Minimum
Debt Instrument [Line Items]
Covenant, Fixed charge coverage	1.50%

Summary of Outstanding Mortgage

Summary of Outstanding Mortgages, Excluding Net Debt Premium (Detail) - USD ($) $ in Thousands		6 Months Ended
		Jun. 30, 2016		Dec. 31, 2015
Debt Instrument [Line Items]
Outstanding Balance		$ 108,660	[1]	$ 110,300
Summerlin Hospital Medical Office Building III floating rate mortgage loan
Debt Instrument [Line Items]
Outstanding Balance	[1],[2]	$ 10,538
Debt Instrument Interest Rate Stated Percentage	[2]	3.72%
Maturity Date	[2]	2016-12
Peace Health fixed rate mortgage loan
Debt Instrument [Line Items]
Outstanding Balance	[1],[2]	$ 20,553
Debt Instrument Interest Rate Stated Percentage	[2]	5.64%
Maturity Date	[2]	2017-04
Auburn Medical II floating rate mortgage loan
Debt Instrument [Line Items]
Outstanding Balance	[1],[2]	$ 6,840
Debt Instrument Interest Rate Stated Percentage	[2]	3.21%
Maturity Date	[2]	2017-04
Medical Center of Western Connecticut fixed rate mortgage loan
Debt Instrument [Line Items]
Outstanding Balance	[1],[2]	$ 4,600
Debt Instrument Interest Rate Stated Percentage	[2]	6.00%
Maturity Date	[2]	2017-06
Summerlin Hospital Medical Office Building II fixed rate mortgage loan
Debt Instrument [Line Items]
Outstanding Balance	[1]	$ 11,257
Debt Instrument Interest Rate Stated Percentage		5.50%
Maturity Date		2017-10
Phoenix Children's East Valley Care Center Fixed Rate Mortgage Loan
Debt Instrument [Line Items]
Outstanding Balance	[1]	$ 6,276
Debt Instrument Interest Rate Stated Percentage		5.88%
Maturity Date		2017-12
Centennial Hills Medical Office Building floating rate mortgage loan
Debt Instrument [Line Items]
Outstanding Balance	[1]	$ 10,191
Debt Instrument Interest Rate Stated Percentage		3.72%
Maturity Date		2018-01
Sparks Medical Building/Vista Medical Terrace Floating Rate Mortgage Loan
Debt Instrument [Line Items]
Outstanding Balance	[1]	$ 4,290
Debt Instrument Interest Rate Stated Percentage		3.72%
Maturity Date		2018-02
Rosenberg Children's Medical Plaza Fixed Rate Mortgage Loan
Debt Instrument [Line Items]
Outstanding Balance	[1]	$ 8,233
Debt Instrument Interest Rate Stated Percentage		4.85%
Maturity Date		2018-05
Vibra Hospital-Corpus Christi fixed rate mortgage loan
Debt Instrument [Line Items]
Outstanding Balance	[1]	$ 2,770
Debt Instrument Interest Rate Stated Percentage		6.50%
Maturity Date		2019-07
700 Shadow Lane and Goldring MOBs fixed rate mortgage loan
Debt Instrument [Line Items]
Outstanding Balance	[1]	$ 6,339
Debt Instrument Interest Rate Stated Percentage		4.54%
Maturity Date		2022-06
BRB Medical Office Building fixed rate mortgage loan
Debt Instrument [Line Items]
Outstanding Balance	[1]	$ 6,408
Debt Instrument Interest Rate Stated Percentage		4.27%
Maturity Date		2022-12
Desert Valley Medical Center Floating Rate Mortgage Loan
Debt Instrument [Line Items]
Outstanding Balance	[1]	$ 5,146
Debt Instrument Interest Rate Stated Percentage		3.62%
Maturity Date		2023-01
Tuscan Professional Building fixed rate mortgage loan
Debt Instrument [Line Items]
Outstanding Balance	[1]	$ 5,219
Debt Instrument Interest Rate Stated Percentage		5.56%
Maturity Date		2025-06
[1]	All mortgage loans require monthly principal payments through maturity and either fully amortize or include a balloon principal payment upon maturity.
[2]	This loan is scheduled to mature within the next twelve months, at which time we will decide whether to refinance pursuant to a new mortgage loan or by utilizing borrowings under our Credit Agreement.

Segment Reporting - Additional

Segment Reporting - Additional Information (Detail)	6 Months Ended
	Jun. 30, 2016Segment
Segment Reporting [Abstract]
Number of reportable segments	1